Summary
GBI Research, the leading business intelligence provider, has released its latest research "The Future of Cardiovascular Diseases Therapeutics-Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis." The report provides in-depth analysis of unmet needs, drivers and barriers that impact the global cardiovascular diseases therapeutics market. The report analyzes the markets for cardiovascular disease therapeutics in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. Treatment usage patterns, sales, price and volume are forecast until 2015 for the key geographies as well as the leading therapeutic segments. Further, the report provides competitive benchmarking for the leading companies and also analyzes the mergers, acquisitions and licensing agreements that shape the global markets.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.

Scope
The scope of this report includes:
-Annualized market data for the cardiovascular diseases therapeutics market from 2000 to 2008, forecast forward to 2015
-Analysis of the leading therapeutic segments including hypertension, dyslipidemia and thrombosis
-Analysis of the cardiovascular diseases therapeutics market in the leading geographies of the world, which include the US, the UK, Germany, France, Italy, Spain, and Japan
-Market characterization of the cardiovascular diseases therapeutics market including market size, annual cost of therapy, sales volume and treatment usage patterns
-Key drivers and barriers that have a significant impact on the market
-Coverage of pipeline molecules in various phases of drug development
-Competitive benchmarking of leading companies. The key companies studied in this report are Novartis AG, Sanofi-aventis,  Pfizer Inc and Merck & Co
-Key M&A activities, licensing agreements, that have taken place between 2008 and 2009 in the global cardiovascular diseases therapeutics market

Reasons to buy
The report will aid Business Development and marketing executives strategizing their product launches. It will allow you to;
-Develop and design your in-licensing and out-licensing strategies through review of pipeline products and technologies and by identifying companies with the most robust pipeline.
-Develop business strategies by understanding the trends shaping and driving the cardiovascular diseases therapeutics market.
-Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the cardiovascular diseases therapeutics market in future.
-Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
-Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
-Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
-What's the next big thing in the global cardiovascular diseases therapeutics landscape?-Identify, understand and capitalize.

Table of Contents
1 Table of Contents
1 Table of Contents 4
1.1 List of Tables 7
1.2 List of Figures 11
2 Global Cardiovascular Therapeutics Market: Scope of Research 13
2.1 Introduction 13
2.2 GBI Research Report Guidance 13
3 Global Cardiovascular Therapeutics Market: Market Characterization 14
3.1 Market Forecasts 14
3.2 Branded Vs Generics 15
3.3 Average Cost of Therapy 16
3.4 Volume 17
3.5 Usage Patterns 18
3.5.1 Diseased Population 18
3.5.2 Treatment Seeking Population 19
3.5.3 Diagnosis Population 21
3.5.4 Prescription Population 22
3.5.5 Usage Patterns 23
3.5.6 Geographical Distribution 24
4 Global Cardiovascular Therapeutics Market: US Market 25
4.1 Market Overview 25
4.2 Market Forecasts 25
4.3 Average Cost of Therapy 26
4.4 Volume 27
4.5 Usage Patterns 28
4.5.1 Diseased Population 28
4.5.2 Treatment Seeking Population 29
4.5.3 Diagnosis Population 30
4.5.4 Prescription Population 31
4.5.5 Usage Patterns 32
5 Global Cardiovascular Therapeutics Market: European Market 34
5.1 Market Overview 34
5.2 Market Forecasts 34
5.3 Average Cost of Therapy 35
5.4 Volume 36
5.5 Usage Patterns 37
5.5.1 Diseased Population 37
5.5.2 Treatment Seeking Population 38
5.5.3 Diagnosis Population 39
5.5.4 Prescription Population 40
5.5.5 Usage Patterns 41
6 Global Cardiovascular Therapeutics Market: Japan Market 43
6.1 Market Forecasts 43
6.2 Average Cost of Therapy 44
6.3 Volume 45
6.4 Usage Patterns 46
6.4.1 Diseased Population 46
6.4.2 Treatment Seeking Population 47
6.4.3 Prescription Population 49
6.4.4 Usage Patterns 49
7 Global Hypertension Therapeutics Market 51
7.1 Market Forecasts 51
7.2 Average Cost of Therapy 52
7.3 Volume 53
7.4 Usage Patterns 54
7.4.1 Diseased Population 54
7.4.2 Treatment Seeking Population 55
7.4.3 Diagnosis Population 56
7.4.4 Prescription Population 57
7.4.5 Usage Patterns 58
8 Global Dyslipidemia Therapeutics Market 60
8.1 Market Forecasts 60
8.2 Average Cost of Therapy 61
8.3 Volume 62
8.4 Usage Patterns 63
8.4.1 Diseased Population 63
8.4.2 Treatment Seeking Population 64
8.4.3 Diagnosis Population 65
8.4.4 Prescription Population 66
8.4.5 Usage Patterns 67
9 Global Thrombosis Therapeutics Market 69
9.1 Market Forecasts 69
9.2 Volume 70
9.3 Average Cost of Therapy 71
9.4 Usage Patterns 72
9.4.1 Diseased Population 72
9.4.2 Treatment Seeking Population 73
9.4.3 Diagnosis Population 74
9.4.4 Prescription Population 75
9.4.5 Usage Patterns 76
10 Global Cardiovascular Therapeutics Market: Market Drivers and Restraints 78
10.1 Market Drivers 78
10.1.1 Steady Increase in the Elderly Population 78
10.1.2 Stable Increase in Incidence Rates for Cardiovascular Diseases 79
10.1.3 Increase in Awareness Levels of Disease Progression and Etiology 79
10.2 Market Restraints 79
10.2.1 Patent Expirations and Entry of Generics Pose a Serious Problem for Primary Manufacturers 79
10.2.2 Reimbursement Restrictions on Drug Classes for Certain Cardiovascular Disease Drug Classes Restricts the Market Growth 80
11 Global Cardiovascular Therapeutics Market: Unmet Needs 81
12 Global Cardiovascular Therapeutics Market: Key Market Trends 82
12.1 Increase in Disease Incidence and Prevalence Rates 82
12.2 Product Pipeline 82
12.3 Advertising and Commercialization 83
12.4 Regulatory trends-Current Reimbursement Scenario 83
12.4.1 The Budget Impact on Drug Reimbursements 83
12.4.2 Reliability of Generic Formulations as a Cost Cutting Measure 83
13 Global Cardiovascular Therapeutics Market: Competitive Landscape 84
13.1 Overview 84
13.2 Market Share Analysis 84
13.3 Competitive Profiling 85
13.3.1 Pfizer 86
13.3.2 Sanofi-Aventis 86
13.3.3 Merck 87
13.3.4 Novartis 87
14 Global Cardiovascular Therapeutics Market: M&A Landscape 88
14.1 Mergers and Acquisitions 88
14.1.1 Overview 88
14.2 Licensing Agreements 90
14.2.1 Research Phase 93
14.2.2 Preclinical 93
14.2.3 Phase I 94
14.2.4 Phase PI/II 94
14.2.5 Phase II 95
14.2.6 Phase III 96
14.2.7 Filed 96
15 Global Cardiovascular Therapeutics Market: Appendix 98
15.1 Market Definitions 98
15.2 Abbreviations 98
15.3 Research Methodology 98
15.3.1 Coverage 99
15.3.2 Secondary Research 99
15.3.3 Forecasts 100
15.3.4 Primary Research 102
15.3.5 Expert Panels 102
15.4 Contact Us 102
15.5 Disclaimer 102

List of Tables
1.1 List of Tables
Table 1: Global Cardiovascular Therapeutics Market, Historical Revenues ($m), 2000-2008 14
Table 2:  Global Cardiovascular Therapeutics Market, Revenue Forecasts ($m), 2008-2015 14
Table 3: Global Cardiovascular Therapeutics Market, Revenue Segmentation, 2000-2008 15
Table 4: Global Cardiovascular Therapeutics Market, Revenue Segmentation, 2008-2015 16
Table 5:   Global Cardiovascular Therapeutics Market, Historical Figures for Average Cost of Therapy ($), 2000-2008 16
Table 6:   Global Cardiovascular Therapeutics Market, Historical Figures for Average Cost of Therapy ($), 2008-2015 17
Table 7:   Global Cardiovascular Therapeutics Market, Historical Figures for Volume,  2000-2008 17
Table 8: Global Cardiovascular Therapeutics Market, Forecasts for Volume, 2008-2015 18
Table 9:   Global Cardiovascular Therapeutics Market, Historical Figures for Diseased Population, 2000-2008 19
Table 10: Global Cardiovascular Therapeutics Market, Forecasts for Diseased Population , 2008-2015 19
Table 11:  Global Cardiovascular Therapeutics Market, Historical Figures for Treatment Seeking Population, 2000-2008 20
Table 12:  Global Cardiovascular Therapeutics Market, Forecasts for Treatment Seeking Population, 2008-2015 20
Table 13:  Global Cardiovascular Therapeutics Market, Historical Figures for Diagnosis Population, 2000-2008 21
Table 14:  Global Cardiovascular Therapeutics Market, Forecasts for Diagnosis Population, 2008-2015 21
Table 15: Global Cardiovascular Therapeutics Market, Historical Figures for Prescription Population, 2000-2008 22
Table 16: Global Cardiovascular Therapeutics Market, Forecasts for Prescription Population, 2008-2015 22
Table 17: Global Cardiovascular Therapeutics Market, Historical Figures for Usage Patterns, 2000-2008 23
Table 18: Global Cardiovascular Therapeutics Market, Forecasts for Usage Patterns,  2008-2015 24
Table 19: US Cardiovascular Therapeutics Market, Historical Revenues ($m), 2000-2008 26
Table 20: US Cardiovascular Therapeutics Market, Revenue Forecasts ($m), 2008-2015 26
Table 21:  US Cardiovascular Therapeutics Market, Historical Figures for the Average Cost of Therapy ($), 2000-2008 27
Table 22:  US Cardiovascular Therapeutics Market, Forecasts for the Average Cost of Therapy ($), 2008-2015 27
Table 23: US Cardiovascular Therapeutics Market, Historical Figures for Volume,  2000-2008 27
Table 24: US Cardiovascular Therapeutics Market, Forecasts for Volume, 2008-2015 28
Table 25:  US Cardiovascular Therapeutics Market, Historical Figures for Diseased Population, 2000-2008 28
Table 26:  US Cardiovascular Therapeutics Market, Forecasts for Diseased Population, 2008-2015 29
Table 27:  US Cardiovascular Therapeutics Market, Historical Figures for Treatment Seeking Population, 2000-2008 30
Table 28:  US Cardiovascular Therapeutics Market, Forecasts for Treatment Seeking Population, 2008-2015 30
Table 29:  US Cardiovascular Therapeutics Market, Historical Figures for Diagnosis Population(000'), 2000-2008 31
Table 30:  US Cardiovascular Therapeutics Market, Forecasts for Diagnosis Population(000'), 2008-2015 31
Table 31:  US Cardiovascular Therapeutics Market, Historical Figures for Prescription Population, 2000-2008 32
Table 32:  US Cardiovascular Therapeutics Market, Forecasts for Prescription Population, 2008-2015 32
Table 33:  US Cardiovascular Therapeutics Market, Historical Figures for Usage Patterns, 2000-2008 33
Table 34:  US Cardiovascular Therapeutics Market, Forecasts for Usage Patterns,  2008-2015 33
Table 35: European Cardiovascular Therapeutics Market, Historical Revenues ($bn),  2000-2008 34
Table 36:  European Cardiovascular Therapeutics Market, Revenue Forecasts ($m),  2008-2015 35
Table 37:  European Cardiovascular Therapeutics Market, Historical Figures for Average Cost of Treatment, 2000-2008 35
Table 38:  European Cardiovascular Therapeutics Market, Forecasts for Average Cost of Treatment, 2008-2015 36
Table 39: European Cardiovascular Therapeutics Market, Historical Figures for Volume, 2000-2008 36
Table 40:  European Cardiovascular Therapeutics Market, Forecasts for Volume,  2008-2015 37
Table 41:  European Cardiovascular Therapeutics Market, Historical Figures for Diseased Population, 2000-2008 37
Table 42:  European Cardiovascular Therapeutics Market, Forecasts for Diseased Population, 2008-2015 38
Table 43:  European Cardiovascular Therapeutics Market, Historical Figures for Treatment Seeking Population, 2000-2008 38
Table 44:  European Cardiovascular Therapeutics Market, Forecasts for Treatment Seeking Population, 2008-2015 39
Table 45:  European Cardiovascular Therapeutics Market, Historical Figures for Diagnosis Population, 2000-2008 39
Table 46:  European Cardiovascular Therapeutics Market, Forecasts for Diagnosis Population, 2008-2015 40
Table 47:  European Cardiovascular Therapeutics Market, Historical Figures for Prescription Population, 2000-2008 40
Table 48:  European Cardiovascular Therapeutics Market, Forecasts for Prescription Population, 2008-2015 41
Table 49:  European Cardiovascular Therapeutics Market, Historical Figures for Usage Patterns, 2000-2008 42
Table 50:  European Cardiovascular Therapeutics Market, Forecasts for Usage Patterns, 2008-2015 42
Table 51: Japan Cardiovascular Therapeutics Market, Historical Revenues ($m), 2000-2008 43
Table 52: Japan Cardiovascular Therapeutics Market, Revenue Forecasts ($m), 2008-2015 43
Table 53:  Japan Cardiovascular Therapeutics Market, Historical Figures for Average Cost of Therapy ($), 2000-2008 44
Table 54:  Japan Cardiovascular Therapeutics Market, Forecasts for Average Cost of Therapy ($), 2008-2015 44
Table 55: Japan Cardiovascular Therapeutics Market, Historical Figures for Volume,  2000-2008 45
Table 56: Japan Cardiovascular Therapeutics Market, Forecasts for Volume, 2008-2015 45
Table 57:  Japan Cardiovascular Therapeutics Market, Historical Figures for Diseased  Population, 2000-2008 46
Table 58:  Japan Cardiovascular Therapeutics Market, Forecasts for Diseased Population, 2008-2015 46
Table 59:  Japan Cardiovascular Therapeutics Market, Historical Figures for Treatment Seeking Population, 2000-2008 47
Table 60:  Japan Cardiovascular Therapeutics Market, Forecasts for Treatment Seeking Population, 2008-2015 47
Table 61:  Japan Cardiovascular Therapeutics Market, Historical Figures for Diagnosis Population, 2000-2008 48
Table 62: Japan Cardiovascular Therapeutics Market, Forecasts for Diagnosis Population, 2008-2015 48
Table 63:  Japan Cardiovascular Therapeutics Market, Historical Figures for Prescription Population, 2000-2008 49
Table 64:  Japan Cardiovascular Therapeutics Market, Forecasts for Prescription Population, 2008-2015 49
Table 65:  Japan Cardiovascular Therapeutics Market, Historical Figures for Usage Patterns, 2000-2008 50
Table 66:  Japan Cardiovascular Therapeutics Market, Forecasts for Usage Patterns,  2008-2015 50
Table 67: Global Hypertension Therapeutics Market, Historical Revenues ($m), 2000-2008 51
Table 68: Global Hypertension Therapeutics Market, Revenue Forecasts ($m), 2008-2015 51
Table 69:  Global Hypertension Therapeutics Market, Historical Figures for the Average Cost of Therapy ($), 2000-2008 52
Table 70:  Global Hypertension Therapeutics Market, Forecast Figures for the Average Cost of Therapy ($), 2008-2015 52
Table 71:  Global Hypertension Therapeutics Market, Historical Figures for Volume,  2000-2008 53
Table 72: Global Hypertension Therapeutics Market, Forecasts for Volume, 2008-2015 53
Table 73:  Global Hypertension Therapeutics Market, Historical Figures for Diseased Population, 2000-2008 54
Table 74:  Global Hypertension Therapeutics Market, Forecasts for Diseased Population, 2008-2015 54
Table 75:  Global Hypertension Therapeutics Market, Historical Figures for Treatment Seeking Population, 2000-2008 55
Table 76:  Global Hypertension Therapeutics Market, Forecasts for Treatment Seeking Population, 2008-2015 55
Table 77:  Global Hypertension Therapeutics Market, Historical Figures for Diagnosis Population, 2000-2008 56
Table 78:  Global Hypertension Therapeutics Market, Forecasts for Diagnosis Population, 2008-2015 56
Table 79: Global Hypertension Therapeutics Market, Historical Figures for Prescription Population, 2000-2008 57
Table 80: Global Hypertension Therapeutics Market, Forecasts for Prescription Population, 2008-2015 57
Table 81: Global Hypertension Therapeutics Market, Historical Figures for Usage Patterns, 2000-2008 58
Table 82: Global Hypertension Therapeutics Market, Forecasts for Usage Patterns,  2008-2015 59
Table 83: Global Dyslipidemia Therapeutics Market, Historical Revenues ($m), 2000-2008 60
Table 84: Global Dyslipidemia Therapeutics Market, Revenue Forecasts ($m), 2008-2015 60
Table 85: Global Dyslipidemia Therapeutics Market, Historical Figures for the Average Cost of Therapy ($), 2000-2008 61
Table 86: Global Dyslipidemia Therapeutics Market, Forecast Figures for the Average Cost of Therapy ($), 2008-2015 61
Table 87: Global Dyslipidemia Therapeutics Market, Historical Figures for Volume,  2000-2008 62
Table 88: Global Dyslipidemia Therapeutics Market, Forecasts for Volume, 2008-2015 62
Table 89: Global Dyslipidemia Therapeutics Market, Historical Figures for Diseased Population, 2000-2008 63
Table 90: Global Dyslipidemia Therapeutics Market, Forecasts for Diseased Population, 2008-2015 63
Table 91: Global Dyslipidemia Therapeutics Market, Historical Figures for Treatment Seeking Population, 2000-2008 64
Table 92: Global Dyslipidemia Therapeutics Market, Forecasts for Treatment Seeking Population, 2008-2015 64
Table 93: Global Dyslipidemia Therapeutics Market, Historical Figures for Diagnosis Population, 2000-2008 65
Table 94: Global Dyslipidemia Therapeutics Market, Forecasts for Diagnosis Population, 2008-2015 65
Table 95: Global Dyslipidemia Therapeutics Market, Historical Figures for Prescription Population, 2000-2008 66
Table 96: Global Dyslipidemia Therapeutics Market, Forecasts for Prescription Population, 2008-2015 66
Table 97: Global Dyslipidemia Therapeutics Market, Historical Figures for Usage Patterns, 2000-2008 67
Table 98: Global Dyslipidemia Therapeutics Market, Forecasts for Usage Patterns,  2008-2015 68
Table 99: Global Thrombosis Therapeutics Market, Historical Revenues ($m), 2000-2008 69
Table 100: Global Thrombosis Therapeutics Market, Revenue Forecasts ($m), 2008-2015 69
Table 101: Global Thrombosis Therapeutics Market, Historical Figures for Volume,  2000-2008 70
Table 102: Global Thrombosis Therapeutics Market, Forecasts for Volume, 2008-2015 70
Table 103: Global Thrombosis Therapeutics Market, Historical Figures for Average Cost of Therapy ($), 2000-2008 71
Table 104: Global Thrombosis Therapeutics Market, Forecasts for Average Cost of Therapy ($), 2008-2015 71
Table 105: Global Thrombosis Therapeutics Market, Historical Figures for Diseased Population, 2000-2008 72
Table 106: Global Thrombosis Therapeutics Market, Forecast Figures for Diseased Population, 2008-2015 72
Table 107: Global Thrombosis Therapeutics Market, Historical Figures for Treatment Seeking Population, 2000-2008 73
Table 108: Global Thrombosis Therapeutics Market, Forecasts for Treatment Seeking Population, 2008-2015 73
Table 109: Global Thrombosis Therapeutics Market, Historical Figures for Diagnosis Population, 2000-2008 74
Table 110: Global Thrombosis Therapeutics Market, Forecasts for Diagnosis Population, 2008-2015 74
Table 111: Global Thrombosis Therapeutics Market, Historical Figures for Prescription Population, 2000-2008 75
Table 112: Global Thrombosis Therapeutics Market, Forecasts for Prescription Population, 2008-2015 75
Table 113: Global Thrombosis Therapeutics Market, Historical Figures for Usage Patterns, 2000-2008 76
Table 114: Global Thrombosis Therapeutics Market, Forecasts for Usage Patterns,  2008-2015 77
Table 115: Global Cardiovascular Therapeutics Market, Market Drivers, 2008 78
Table 116: Global Cardiovascular Therapeutics Market, Market Restraints, 2008 79
Table 117: Global Cardiovascular Therapeutics Market, Major Drug Patent Expirations, 2008-2015 80
Table 118:Global Cardiovascular Therapeutics Market, Licensing Agreements for Drugs in the Research Stage, 2008-2009 93
Table 119: Global Cardiovascular Therapeutics Market, Licensing Agreements for Drugs in the Pre-clinical Stage, 2008-2009 93
Table 120: Global Cardiovascular Therapeutics Market, Licensing Agreements for Drugs in the PI Stage, 2008-2009 94
Table 121: Global Cardiovascular Therapeutics Market, Licensing Agreements for Drugs in the PI/PII Stage, 2008-2009 94
Table 122: Global Cardiovascular Therapeutics Market, Licensing Agreements for Drugs in the PII Stage, 2008-2009 95
Table 123: Global Cardiovascular Therapeutics Market, Licensing Agreements for Drugs in the PIII stage, 2008-2009 96
Table 124: Global Cardiovascular Therapeutics Market, Licensing Agreements for Drugs in the Filed Stage, 2008-2009 96

List of Figures
1.2 List of Figures
Figure 1: Global Cardiovascular Therapeutics Market, Revenue Forecast, 2000-2015 14
Figure 2: Global Cardiovascular Therapeutics Market, Revenue Segmentation, 2000-2015 15
Figure 3: Global Cardiovascular Therapeutics Market, Average Cost of Therapy ($), | 2000-2015 16
Figure 4: Global Cardiovascular Therapeutics Market, Volume, 2000-2015 17
Figure 5:  Global Cardiovascular Therapeutics Market, Global Diseased Population,  2000-2015 18
Figure 6:  Global Cardiovascular Therapeutics Market, Forecasts for Treatment Seeking Population, 2000-2015 20
Figure 7: Global Cardiovascular Therapeutics Market, Forecasts for Diagnosis Population, 2000-2015 21
Figure 8: Global Cardiovascular Therapeutics Market, Forecasts for Prescription Population, 2000-2015 22
Figure 9: Cardiovascular Therapeutics Market, Global, Forecasts for Treatment Patterns, 2000-2015 23
Figure 10: Global Cardiovascular Therapeutics Market, Geographical Distribution of Revenues ($bn), 2000-2015 24
Figure 11: US Cardiovascular Therapeutics Market, Revenue Forecasts ($bn), 2000-2015 25
Figure 12: US Cardiovascular Therapeutics Market, Average Cost of Therapy ($),  2000-2015 26
Figure 13: US Cardiovascular Therapeutics Market, Volume (million), 2000-2015 27
Figure 14: US Cardiovascular Therapeutics Market, Forecasts for Diseased Population,  2000-2015 28
Figure 15: US Cardiovascular Therapeutics Market, Forecasts for Treatment Seeking Population, 2000-2015 29
Figure 16: US Cardiovascular Therapeutics Market, Forecasts for Diagnosis Population, 2000-2015 30
Figure 17: US Cardiovascular Therapeutics Market, Forecasts for Prescription Population, 2000-2015 31
Figure 18: US Cardiovascular Therapeutics Market, Forecasts for Usage Patterns,  2000-2015 32
Figure 19: European Cardiovascular Therapeutics Market, Revenue Forecasts ($bn),  2000-2015 34
Figure 20: European Cardiovascular Therapeutics Market, Forecasts for Average Cost of Treatment ($), 2000-2015 35
Figure 21: European Cardiovascular Therapeutics Market, Forecasts for Volume,  2000-2015 36
Figure 22: European Cardiovascular Therapeutics Market, Forecasts for Diseased Population, 2000-2015 37
Figure 23: European Cardiovascular Therapeutics Market, Forecasts for Treatment Seeking Population, 2000-2015 38
Figure 24: European Cardiovascular Therapeutics Market, Forecasts for Diagnosis Population, 2000-2015 39
Figure 25: European Cardiovascular Therapeutics Market, Forecasts for Prescription Population, 2000-2015 40
Figure 26: European Cardiovascular Therapeutics Market, Forecasts for Usage Patterns, 2000-2015 41
Figure 27: Japan Cardiovascular Therapeutics Market, Revenue Forecasts ($bn),  2000-2015 43
Figure 28: Japan Cardiovascular Therapeutics Market, Forecasts for Average Cost of Therapy ($), 2000-2015 44
Figure 29: Japan Cardiovascular Therapeutics Market, Forecasts for Volume, 2000-2015 45
Figure 30: Japan Cardiovascular Therapeutics Market, Forecasts for Diseased Population, 2000-2015 46
Figure 31: Japan Cardiovascular Therapeutics Market, Forecasts for Treatment Seeking Population, 2000-2015 47
Figure 32: Japan Cardiovascular Therapeutics Market, Forecasts for Diagnosis Population, 2000-2015 48
Figure 33: Japan Cardiovascular Therapeutics Market, Forecasts for Prescription Population, 2000-2015 49
Figure 34: Japan Cardiovascular Therapeutics Market, Forecasts for Usage Patterns, 2000-2015 50
Figure 35: Global Hypertension Therapeutics Market, Revenue Forecasts ($bn), 2000-2015 51
Figure 36: Global Hypertension Therapeutics Market, Average Cost of Therapy ($),  2000-2015 52
Figure 37: Global Hypertension Therapeutics Market, Volume, 2000-2015 53
Figure 38: Global Hypertension Therapeutics Market, Forecasts for Diseased Population, 2000-2015 54
Figure 39: Global Hypertension Therapeutics Market, Forecasts for Treatment Seeking Population, 2000-2015 55
Figure 40: Global Hypertension Therapeutics Market, Forecasts for Diagnosis Population, 2000-2015 56
Figure 41: Global Hypertension Therapeutics Market, Forecasts for Prescription Population, 2000-2015 57
Figure 42: Global Hypertension Therapeutics Market, Forecasts for Usage Patterns,  2000-2015 58
Figure 43: Global Dyslipidemia Therapeutics Market, Revenue Forecasts ($bn), 2000-2015 60
Figure 44: Global Dyslipidemia Therapeutics Market, Average Cost of Therapy ($),  2000-2015 61
Figure 45: Global Dyslipidemia Therapeutics Market, Volume, 2000-2015 62
Figure 46: Global Dyslipidemia Therapeutics Market, Forecasts for Diseased Population, 2000-2015 63
Figure 47: Global Dyslipidemia Therapeutics Market, Forecasts for Treatment Seeking Population, 2000-2015 64
Figure 48: Global Dyslipidemia Therapeutics Market, Forecasts for Diagnosis Population, 2000-2015 65
Figure 49: Global Dyslipidemia Therapeutics Market, Forecasts for Prescription Population, 2000-2015 66
Figure 50: Global Cardiovascular Therapeutics Market, Forecasts for Treatment Patterns, 2000-2015 67
Figure 51: Global Thrombosis Therapeutics Market, Revenue Forecasts ($bn), 2000-2015 69
Figure 52: Global Thrombosis Therapeutics Market, Volume, 2000-2015 70
Figure 53: Global Thrombosis Therapeutics Market, Forecasts for Average Cost of Therapy ($), 2000-2015 71
Figure 54: Global Thrombosis Therapeutics Market, Forecasts for Diseased Population, 2000-2015 72
Figure 55: Global Thrombosis Therapeutics Market, Forecasts for Treatment Seeking Population, 2000-2015 73
Figure 56: Global Thrombosis Therapeutics Market, Forecasts for Diagnosis Population, 2000-2015 74
Figure 57: Global Thrombosis Therapeutics Market, Forecasts for Prescription Population, 2000-2015 75
Figure 58: Global Thrombosis Therapeutics Market, Forecasts for Treatment Patterns, 2000-2015 76
Figure 59: Global Cardiovascular Disease Therapeutics Market, Market Indicators, 2008 78
Figure 60: Global Cardiovascular Therapeutics Market, Analysis of  Unmet Needs for Major Disease Sectors, 2008 81
Figure 61: Global Cardiovascular Disease Therapeutics Market, Key Market Events,  2008-2015 82
Figure 62: Global Cardiovascular Therapeutics Market, Market Share of Top   Manufacturers, 2008 84
Figure 63: Global Cardiovascular Therapeutics Market, Benchmarking Analysis for Top Four Manufacturers, 2008 85
Figure 64: Global Cardiovascular Therapeutics Market, Benchmarking Analysis for Top Four Manufacturers Pipeline and Unmet Need Analysis, 2008 85
Figure 65: Global Cardiovascular Therapeutics Market, M&A Deals by Geography, 2008 88
Figure 66: Global Cardiovascular Therapeutics Market, M&A Deals by Deal Size, 2008 88
Figure 67: Global Cardiovascular Therapeutics Market, M&A Deals by Phase, 2008 89
Figure 68: Global Cardiovascular Therapeutics Market, Top Three M&A Deals, 2008 89
Figure 69: Global Cardiovascular Therapeutics Market, Licensing Agreement by Geography, 2008 91
Figure 70: Global Cardiovascular Therapeutics Market, Licensing Agreement by Deal Size, 2008 91
Figure 71: Global Cardiovascular Therapeutics Market, Licensing Agreements by Phase of Development, 2008 92
Figure 72: Global Cardiovascular Therapeutics Market, Licensing Agreement by Indications, 2008 92
Figure 73: GBI Research Methodology 99
Figure 74: GBI Research Market Forecasting Methodology 101